Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study

Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study

Mid-regional pro-adrenomedullin (MR-proADM), methemoglobin (MetHb), and carboxyhemoglobin (COHb) levels have been associated with sepsis. In this study, we assessed the role of this potential biomarkers in critically ill COVID-19 patients. Outcomes were mortality and a combined event (mortality, ven...

Full description

Bibliographic Details
Main Authors: Crhistian-Mario Oblitas, Francisco Galeano-Valle, Jesús Ramírez-Navarro, Jorge López-Cano, Ángel Monterrubio-Manrique, Mercedes García-Gámiz, Milagros Sancho-González, Sara Arenal-López, Luis-Antonio Álvarez-Sala Walther, Pablo Demelo-Rodríguez
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Viruses
Subjects:
biomarkers
COHb
MetHb
mortality
MR-pro-ADM
SARS-CoV-2
Online Access:https://www.mdpi.com/1999-4915/13/12/2445

Internet

https://www.mdpi.com/1999-4915/13/12/2445

Similar Items